Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Estradiol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,822Xls

    Filters

    clear-filterReset all filters

    PRINCIPAL DISPLAY PANEL - Package Label – 0.05/0.25 mg per day

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR

    PRINCIPAL DISPLAY PANEL - Package Label – 0.05/0.25 mg per day

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR

    1/0.5 carton

    TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    1/0.5 carton

    TABLET;ORAL - 1MG;0.5MG

    PharmaCompass

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR

    PharmaCompass

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.025MG/24HR

    PharmaCompass

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.0375MG/24HR

    PharmaCompass

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR

    PharmaCompass

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.06MG/24HR

    PharmaCompass

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.075MG/24HR

    PharmaCompass

    FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/24HR

    PharmaCompass

    SYSTEM;TRANSDERMAL - 0.025MG/24HR

    PharmaCompass

    SYSTEM;TRANSDERMAL - 0.0375MG/24HR

    PharmaCompass

    SYSTEM;TRANSDERMAL - 0.05MG/24HR

    PharmaCompass

    SYSTEM;TRANSDERMAL - 0.075MG/24HR

    PharmaCompass

    SYSTEM;TRANSDERMAL - 0.1MG/24HR

    PharmaCompass

    GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION)

    PharmaCompass

    TABLET;ORAL - 0.25MG;0.5MG

    PharmaCompass

    TABLET;ORAL - 0.5MG;1MG

    PharmaCompass

    SPRAY;TRANSDERMAL - 1.53MG/SPRAY

    PharmaCompass

    GEL, METERED;TRANSDERMAL - 0.06% (1.25GM/ACTIVATION)

    PharmaCompass

    GEL;TRANSDERMAL - 0.1% (0.25GM/PACKET)

    PharmaCompass

    GEL;TRANSDERMAL - 0.1% (0.5GM/PACKET)

    PharmaCompass

    GEL;TRANSDERMAL - 0.1% (0.75GM/PACKET)

    PharmaCompass

    GEL;TRANSDERMAL - 0.1% (1.25GM/PACKET)

    PharmaCompass

    GEL;TRANSDERMAL - 0.1% (1GM/PACKET)

    PharmaCompass

    TABLET;VAGINAL - 10MCG

    PharmaCompass

    TABLET;VAGINAL - 25MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    PharmaCompass

    CAPSULE;ORAL - 0.5MG;100MG

    PharmaCompass

    CAPSULE;ORAL - 1MG;100MG

    PharmaCompass

    CREAM;VAGINAL - 0.01%

    PharmaCompass

    INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR

    X
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.